Evaluate the Safety, Tolerability and Efficacy of PN-101 in Patients With Refractory Polymyositis or Dermatomyositis
Conditions:   Polymyositis;   Dermatomyositis Intervention:   Biological: PN-101 Sponsor:   Paean Biotechnology Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2021 Category: Research Source Type: clinical trials

Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)
Conditions:   Polymyositis;   Dermatomyositis Intervention:   Drug: MESENCHYMAL STROMAL CELLS (MSC's) Sponsor:   University of Florida Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2021 Category: Research Source Type: clinical trials